Bausch Health’s Q3 earnings beat, growth at Salix and higher outlook were cited alongside a reported share gain.
Bausch Health Companies Inc. reported a third-quarter earnings beat, growth at Salix and a higher outlook, according to an October 29 headline. The headline also reported a 9% stock gain. The supplied quote data show a C$12.08 last close and a 28.34% one-day gain. The available information does not include earnings or revenue figures, Salix’s growth rate or details of the revised outlook.
Investor takeaway: The headline links Bausch Health’s Q3 earnings beat and higher outlook to growth at Salix. But the supplied information does not quantify the results or the outlook change.
Bausch Health Companies Inc
BHC.TO
BHC.TO
Bausch Health Companies Inc
WealthAwesomeMarket cap
$4.64B
52W high
$12.65
52W low
$6.10
1W change
+36.52%
Beta
0.37
Analyst Price Targets
Based on analyst covering BHC · as of Sep 17, 2026
Wall Street analysts forecast BHC stock price to fall 43.5% over the next 12 months.
Consensus
BearishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$7.01
-43.5% Upside
Current Price
C$12.41
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
79.9%
Annualized
90-Day Vol
78.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$14.84
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$13.17 | C$10.00 – C$17.35 |
| 60 trading days | C$13.98 | C$9.47 – C$20.64 |
| 90 trading days | C$14.84 | C$9.20 – C$23.92 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
C$12.08 last close; 28.34% one-day move
The supplied quote data show a C$12.08 last close and a 28.34% one-day gain. Latest reported volume was 263,695 shares, below the 20-day average of 469,103. A separate figure says volume was 7.30 times its average, but that does not match the reported volume figures.
Bull case
The reported Q3 earnings beat, growth at Salix and higher outlook are positive signs in the event headline.
Bear case
The available information does not include earnings or revenue figures, a measure of Salix’s growth or details of the higher outlook. Bausch Health also reported negative trailing-twelve-month EPS and profit margin in the supplied data.
Q3 earnings beat and higher outlook lead the event
An October 29 headline says Bausch Health beat Q3 earnings expectations, citing growth at Salix and a higher outlook. It also reports a 9% stock gain. The supplied information does not include earnings or revenue results, specify what part of the outlook was raised or quantify Salix’s contribution. Without those details, it’s not possible to assess the scale of the operating improvement. Investors can follow BHC.TO on Bausch Health’s stock page.
The supplied quote shows a sharp one-day move
Bausch Health’s last close was C$12.08, and the supplied performance data show a 28.34% one-day gain. The close was within the stated 52-week range of C$6.10 to C$12.65. Latest volume was 263,695 shares, compared with a 20-day average of 469,103. Those figures do not support the separate claim that volume was 7.30 times its average. The data also show trailing-twelve-month EPS of -C$4.08 and a profit margin of -10.1%. These figures provide context but do not explain the quarter’s results.
Quarterly details will clarify what changed
The headline points to several details worth checking: Q3 earnings and revenue, the amount and source of Salix’s growth, and the specific terms of the higher outlook. That information would help show whether the earnings beat and revised outlook reflect Salix or broader business results. Until those details are available, the event is clear, but its scale and durability cannot be assessed from the supplied information. More company information is available on the BHC.TO stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
